Every year following Lung Leavin’ Day, I write a recap of the evening. This year I wanted to do something a little different. I know the event has a huge effect on people, and in the last couple of years people have shared their feelings about the night with me. I thought I would ask a few friends about their thoughts on the tradition and share them with you.
Doctors use information about each case of mesothelioma to help guide the treatment of each patient. Most commonly, doctors look at how far the mesothelioma has spread which is measured in the tumor-node-metastasis (TNM) stage and the type of tumor cell --epithelioid, biphasic, and sarcomatoid. However, even the same type of mesothelioma—epithelioid— can vary in its rate of growth or aggressiveness. Thus, other factors in mesothelioma must affect its aggressiveness.
Research is at the heart of the International Mesothelioma Program (IMP) at Brigham and Women’s Hospital (BWH) in Boston. By studying mesothelioma tumors, our team of physician-scientists has made incredible strides in the search for mutations that can lead to mesothelioma. Their findings support the current understanding that mesothelioma begins with exposure to an irritant—usually asbestos—that triggers a cascade of genetic changes resulting in the disease.
A cancer diagnosis triggers fear and worry in most, if not all people. Many new terms and treatment options are provided to you at diagnosis. For some people, it can become overwhelming. To help alleviate these feelings in the beginning of your cancer journey, bring a friend or family member to your appointments to help understand the information, ask questions, and take notes. Make sure you ask questions until you understand the answers and the options you have during your treatment.
The Mesothelioma Cancer Alliance would like to welcome Tanita Taylor to our blog as February's Advocate of the Month. Tanita is a proud mother of 2 and shares her experiences on her blog Just Motherhood. Today, Tanita shares the story of how mesothelioma affected her grandmother's life and her family's life.
Talking about cancer is never easy, but talking about cancer with your children may be one of the most difficult conversations to think about having. It’s one of those things no parent plans on having to deal with.
Many chemotherapy regimens can damage nerves that serve most of the body, called peripheral nerves. This damage, technically called chemotherapy-induced peripheral neurotherapy (CIPN), causes pain in about 60% of chemotherapy- treated patients.1 While it often begins after the later cycles, it can linger for years.
We are pleased and proud to award the first Mesothelioma Cancer Alliance Scholarship to Olivia Current.
Olivia is a four-year cancer survivor. In 2011, at the age of 16, she was diagnosed with Acute Myeloid Leukemia, and her subsequent treatment required not only rounds of intense chemotherapy but also a bone-marrow transplant to address a DNA mutation. Olivia’s experience was fraught with complications from infections to graft-versus-host disease (GVHD), a condition in which the newly transplanted tissue attacks the receiver’s system.